| Document and Entity Information - shares | 9 Months Ended | |
| Dec. 31, 2018 | Feb. 26, 2019 | |
| Document And Entity Information | ||
| Entity Registrant Name | Celexus, Inc | |
| Entity Central Index Key | 0001355559 | |
| Document Type | 10-Q | |
| Document Period End Date | Dec. 31, 2018 | |
| Amendment Flag | false | |
| Current Fiscal Year End Date | --03-31 | |
| Is Entity's Reporting Status Current? | Yes | |
| Is Entity Emerging Growth Company? | true | |
| Elected Not To Use the Extended Transition Period | true | |
| Entity Filer Category | Non-accelerated Filer | |
| Entity Small Business | true | |
| Entity Common Stock, Shares Outstanding | 565,864,527 | |
| Document Fiscal Period Focus | Q3 | |
| Document Fiscal Year Focus | 2018 |
| Balance Sheets (Unaudited) - USD ($) | Dec. 31, 2018 | Mar. 31, 2018 |
| ASSETS | ||
| Total assets | ||
| Current liabilities | ||
| Accounts payable | 2,570 | 200 |
| Accounts payable - related party | 7,830 | |
| Interest payable - related party | 5,089 | 3,011 |
| Convertible Revolving Demand Note - related party | 25,000 | 25,000 |
| Total current liabilities | 32,659 | 36,041 |
| Total liabilities | 32,659 | 36,041 |
| Commitments and contingencies | ||
| Stockholders' deficit | ||
| Common stock: $0.001 par value; 1,500,000,000 shares authorized, 565,864,527 shares issued and outstanding at December 31, 2018 and March 31, 2018 | 565,865 | 565,865 |
| Additional paid-in capital | 8,318,848 | 8,309,570 |
| Retained deficit | (8,917,372) | (8,911,476) |
| Total stockholders' deficit | (32,659) | (36,041) |
| Total liabilities and stockholders' deficit |
| Balance Sheets (Unaudited) (Parenthetical) - $ / shares | Dec. 31, 2018 | Mar. 31, 2018 |
| Statement of Financial Position [Abstract] | ||
| Common stock, par value | $ 0.001 | $ 0.001 |
| Common stock, authorized shares | 1,500,000,000 | 1,500,000,000 |
| Common stock, issued shares | 565,864,527 | 565,864,527 |
| Common stock, outstanding shares | 565,864,527 | 565,864,527 |
| Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended | ||
| Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | |
| Income Statement [Abstract] | ||||
| Revenue | ||||
| Operating expense | ||||
| Selling, general and administrative | 2,570 | 1,916 | 3,818 | 3,163 |
| Total operating expense | 2,570 | 1,916 | 3,818 | 3,163 |
| Loss from operations | (2,570) | (1,916) | (3,818) | (3,163) |
| Other income (expense) | ||||
| Gain on forgiveness of liabilities | 16,030 | 16,030 | ||
| Interest expense | (712) | (647) | (2,078) | (1,890) |
| Accretion of debt discount | ||||
| Total other income (expense) | (712) | 15,383 | (2,078) | 14,140 |
| Net loss | $ (3,282) | $ 13,467 | $ (5,896) | $ 10,977 |
| Net income per common share: | ||||
| Basic | $ 0 | $ 0 | $ 0 | $ 0 |
| Diluted | $ 0 | $ 0 | ||
| Weighted average number of common and common equivalent shares outstanding: | ||||
| Basic | 565,864,527 | 565,864,527 | 565,864,527 | 565,864,527 |
| Diluted | 565,864,527 | 565,864,527 | ||
| Shareholders Equity (Unaudited) - 9 months ended Dec. 31, 2018 - USD ($) | Common Stock | Additional Paid-In Capital | Retained Deficit | Total |
| Balance at Mar. 31, 2018 | $ 565,865 | $ 8,309,570 | $ (8,911,476) | $ (36,041) |
| Balance, shares at Mar. 31, 2018 | 565,864,527 | |||
| Settlement of liabilities owed to former President | 9,278 | 9,278 | ||
| Net loss | (5,896) | (5,896) | ||
| Balance at Dec. 31, 2018 | $ 565,865 | $ 8,318,848 | $ (8,917,372) | $ (32,659) |
| Balance, shares at Dec. 31, 2018 | 565,864,527 |
| Statements of Cash Flows (Unaudited) - USD ($) | 9 Months Ended | |
| Dec. 31, 2018 | Dec. 31, 2017 | |
| Cash flows from operating activities | ||
| Net loss | $ (5,896) | $ 10,977 |
| Changes in operating assets and liabilities: | ||
| Increase (decrease) in accounts payable and accrued expenses | 3,818 | (12,867) |
| Increase (decrease) in interest payable | 2,078 | 1,890 |
| Net cash flows used in operating activities | ||
| Change in cash and cash equivalents | ||
| Cash and cash equivalents at beginning of period | ||
| Cash and cash equivalents at end of period | ||
| Supplemental disclosure of cash flow information: | ||
| Interest paid in cash | 0 | |
| Income taxes paid in cash | 0 | |
| Supplemental disclosure of non-cash transactions: | ||
| Debt discount recorded for beneficial conversion feature | ||
| Basis of Presentation, Organization and Going Concern | 9 Months Ended |
| Dec. 31, 2018 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| Basis of Presentation, Organization and Going Concern | NOTE 1 – Basis of Presentation, Organization and Going Concern Basis of Presentation The unaudited financial statements of Celexus, Inc. (the “Company”) as of December 31, 2018, and for the three and nine months ended December 31, 2018 and 2017, have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States for interim financial reporting. Accordingly, they do not include all of the disclosures required by accounting principles generally accepted in the United States for complete financial statements and should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended March 31, 2018. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the interim financial information have been included. The Company did not record an income tax provision during the periods presented due to net taxable losses. The results of operations for any interim period are not necessarily indicative of the results of operations for the entire year. Organization Celexus, Inc. (the Company)(formerly Telupay International, Inc.; formerly i-Level Media Group Incorporated; formerly Jackson Ventures, Inc.) was incorporated in the State of Nevada on August 23, 2005 as Jackson Ventures Ltd. and its initial operations included the acquisition and exploration of mineral resources. In March, 2007 the Company changed its name to i-Level Media Group Incorporated (“i-Level”) and changed its business to that of developing and operating a digital media network service. This business ceased operations on December 1, 2008 and its business was wound-up. On September 24, 2013, the Company effected the acquisition of Telupay, PLC by way of a reverse merger. As a result of the Merger, the Company changed its name to Telupay International Inc., effectuated a 1.5-for-1 forward stock split and Telupay became a wholly-owned subsidiary. Telupay was engaged in the mobile banking and payment processing business primarily in the Philippines, Peru, Indonesia, Myanmar and the United Kingdom. Telupay PLC was the primary operating subsidiary of the Company accounting for most of our assets and liabilities. Telupay PLC never reached profitability and was spun out of the Company shortly after December 31, 2014 to the former directors and officers of the Company whereby the business, including the assets and liabilities of Telupay PLC were transferred for no consideration. As a result, the Company had no operations. On January 18, 2017, Barton Hollow, LLC, a limited liability company, was appointed custodian for the Company by the District Court of Clark County, Nevada. The Company was reinstated by the Nevada Secretary of State on November 9, 2017 and on September 9, 2018 changed its name to Celexus, Inc. The Company currently is looking to acquire an operating business or develop a business. The Company’s address is 8275 S. Eastern Ave. Suite 200, Las Vegas, NV 89123, Going Concern The Company’s financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs to allow it to continue as a going concern. As of December 31, 2018, the Company had an accumulated deficit of $8,917,372. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. In view of these conditions, the ability of the Company to continue as a going concern is in doubt and dependent upon achieving a profitable level of operations and on the ability of the Company to obtain necessary financing to fund ongoing operations. Historically, the Company has relied upon internally generated funds and funds from the sale of shares of stock, issuance of promissory notes and loans from its shareholders and private investors to finance its operations and growth. Management is planning to raise necessary additional funds for working capital through loans and/or additional sales of its common stock. However, there is no assurance that the Company will be successful in raising additional capital or that such additional funds will be available on acceptable terms, if at all. Should the Company be unable to raise this amount of capital its operating plans will be limited to the amount of capital that it can access. These financial statements do not give effect to any adjustments which will be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and discharge its liabilities in other than the normal course of business and at amounts different from those reflected in the accompanying financial statements. |
| Debt – Related Party | 9 Months Ended |
| Dec. 31, 2018 | |
| Debt Disclosure [Abstract] | |
| Debt Related Party | NOTE 2 – Debt – Related Party On January 18, 2017, the Company issued a Revolving Demand Note (the “Revolving Demand Note”) to Securities Compliance Group, Ltd. (the “Creditor”) in exchange for services provided by the Creditor. Pursuant the Revolving Demand Note, the Company is liable for $25,000 at an annual interest rate of 9.5% with a default rate of 22%. The Revolving Demand Note may be converted into common stock at an exercise price of par, or $0.001 per share at the discretion of the Creditor. The Revolving Demand Note does not have a maturity date. Since the conversion price was greater than the market price on the date of issuance, the Company did not recognize a debt discount on the Revolving Demand Note. During the three months ended December 31, 2018 and 2017, the Company recognized $712 and $647, respectively, of interest expense. During the nine months ended December 31, 2018 and 2017, the Company recognized $2,078 and $1,890, respectively, of interest expense related to the Revolving Demand Note. |
| Net Loss Per Share | 9 Months Ended |
| Dec. 31, 2018 | |
| Net income per common share: | |
| Net Loss Per Share | NOTE 3 - Net Loss Per Share During the three and nine months ended December 31, 2018 and 2017, the Company recorded a net loss. Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. The Company has not included the effects of convertible debt on net loss per share because to do so would be antidilutive. Following is the computation of basic and diluted net loss per share for the three and nine months ended December 31, 2018 and 2017: Three Months Ended Nine Months Ended December 31, December 31, 2018 2017 2018 2017 Basic and Diluted EPS Computation Numerator: Loss available to common stockholders' $ (3,282 ) $ 13,467 $ (5,896 ) $ 10,977 Denominator: Weighted average number of common shares outstanding Basic 565,864,527 565,864,527 565,864,527 565,864,527 Diluted n/a 568,227,182 n/a 568,227,182 Net income per common share: Basic $ (0.00 ) $ 0.00 $ (0.00 ) $ 0.00 Diluted n/a $ 0.00 n/a $ 0.00 The shares listed below were not included in the computation of diluted losses per share because to do so would have been antidilutive for the periods presented: Convertible debt 5,089,214 — 5,089,214 — |
| Subsequent Events | 9 Months Ended |
| Dec. 31, 2018 | |
| Subsequent Events [Abstract] | |
| Subsequent Events | NOTE 5 – Subsequent Events Management has reviewed material events subsequent of the period ended December 31, 2018 and through February 8, 2019 in accordance with FASB ASC 855 “Subsequent Events”. In February, 2019, Celexus, Inc. entered into an agreement to acquire Bio Distribution, Inc for $13,000,000 worth of stock and $1. Bio Distribution has just acquired the rights to a bio-engineered strain of Hemp seeds that produce low THC levels to meet industry regulations and a high CBD content. Included in the acquisition is a license with the state of Utah to cultivate and supply Hemp seeds and clones. We expect to have 1.5M seeds produced and ready for planting by June of 2019 and another 10M seeds ready for sale by early 2020. This is a related party transaction as Lisa Averbuch is both corps officers and directors. The Company has requested the following corporate actions with FINRA: a 90 to 1 reverse stock split along with the name change to Celexus, Inc. Which will change the outstanding shares from 565,864,827 to 5,073,306. The Company has been informed that FINRA Ops has determined that they will move forward with the requested corporate actions once Form 10 goes effective with the SEC. The Form 10 is effective 60 days from the date of filing. Thus, based on a filing date of 2/5/2019 the Form 10 for this issuer will be effective on 4/6/2019 and the company expects the corporate actions to be effective shortly after that date. |
| Net Loss Per Share (Tables) | 9 Months Ended |
| Dec. 31, 2018 | |
| Net income per common share: | |
| Schedule of basic and diluted net loss per share | Three Months Ended Nine Months Ended December 31, December 31, 2018 2017 2018 2017 Basic and Diluted EPS Computation Numerator: Loss available to common stockholders' $ (3,282 ) $ 13,467 $ (5,896 ) $ 10,977 Denominator: Weighted average number of common shares outstanding Basic 565,864,527 565,864,527 565,864,527 565,864,527 Diluted n/a 568,227,182 n/a 568,227,182 Net income per common share: Basic $ (0.00 ) $ 0.00 $ (0.00 ) $ 0.00 Diluted n/a $ 0.00 n/a $ 0.00 The shares listed below were not included in the computation of diluted losses per share because to do so would have been antidilutive for the periods presented: Convertible debt 5,089,214 — 5,089,214 — |
| Basis of Presentation, Organization and Going Concern (Details Narrative) - USD ($) | Dec. 31, 2018 | Mar. 31, 2018 |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
| Accumulated deficit | $ (8,917,372) | $ (8,911,476) |
| Debt – Related Party (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | |||
| Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | Jan. 18, 2017 | |
| Debt Disclosure [Abstract] | |||||
| Convertible Revolving Demand Note | $ 25,000 | ||||
| Convertible debt annual interest rate | 9.50% | ||||
| Convertible debt annual interest default rate | 22.00% | ||||
| Convertible debt, conversion price per share | $ 0.001 | ||||
| Interest expense | $ (712) | $ (647) | $ (2,078) | $ (1,890) | |
| Net Loss Per Share (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | ||
| Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | |
| Numerator: | ||||
| Loss available to common stockholders' | $ (3,282) | $ 13,467 | $ (5,896) | $ 10,977 |
| Weighted average number of common shares outstanding | ||||
| Basic | 565,864,527 | 565,864,527 | 565,864,527 | 565,864,527 |
| Diluted | 565,864,527 | 565,864,527 | ||
| Net income per common share: | ||||
| Basic | $ 0 | $ 0 | $ 0 | $ 0 |
| Diluted | $ 0 | $ 0 | ||
| The shares listed below were not included in the computation of diluted losses per share because to do so would have been antidilutive for the periods presented: | ||||
| Convertible debt | 5,089,214 | 5,089,214 | ||
| Subsequent Events (Details Narrative) - Subsequent Event [Member] | 1 Months Ended |
| Feb. 26, 2019USD ($) | |
| Stock worth of acquired Bio Distribution | $ 13,000,000 |
| Acquisition agreement description | an agreement to acquire Bio Distribution, Inc for $13,000,000 worth of stock and $1. Bio Distribution has just acquired the rights to a bio-engineered strain of Hemp seeds that produce low THC levels to meet industry regulations and a high CBD content. |
| Reverse stock split | 90 to 1 |
| Stock split, description of changes in outstanding shares | change the outstanding shares from 565,864,827 to 5,073,306 |
